Retirement Systems of Alabama’s Regeneron Pharmaceuticals REGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$79.7M Sell
127,869
-416
-0.3% -$283K 0.24% 72
2026
Q1
$99.1M Sell
128,285
-32
-0% -$24.5K 0.33% 53
2025
Q4
$99M Sell
128,317
-292
-0.2% -$198K 0.32% 55
2025
Q3
$72.3M Sell
128,609
-554
-0.4% -$313K 0.24% 74
2025
Q2
$67.8M Sell
129,163
-2,219
-2% -$1.24M 0.24% 80
2025
Q1
$83.3M Buy
131,382
+108,589
+476% +$74.7M 0.32% 55
2024
Q4
$16.2M Sell
22,793
-374
-2% -$314K 0.06% 329
2024
Q3
$24.4M Sell
23,167
-229
-1% -$255K 0.09% 224
2024
Q2
$24.6M Buy
23,396
+80
+0.3% +$77.6K 0.1% 207
2024
Q1
$22.4M Sell
23,316
-295
-1% -$281K 0.09% 229
2023
Q4
$20.7M Sell
23,611
-525
-2% -$432K 0.09% 222
2023
Q3
$19.9M Sell
24,136
-385
-2% -$303K 0.09% 214
2023
Q2
$17.6M Sell
24,521
-7,255
-23% -$5.59M 0.08% 253
2023
Q1
$26.1M Sell
31,776
-2,530
-7% -$1.91M 0.11% 175
2022
Q4
$24.8M Sell
34,306
-1,297
-4% -$957K 0.11% 186
2022
Q3
$24.5M Sell
35,603
-209
-0.6% -$132K 0.11% 176
2022
Q2
$21.2M Buy
35,812
+455
+1% +$296K 0.09% 216
2022
Q1
$24.7M Sell
35,357
-61,872
-64% -$39.1M 0.09% 212
2021
Q4
$61.4M Sell
97,229
-1,065
-1% -$655K 0.21% 95
2021
Q3
$59.5M Sell
98,294
-2,204
-2% -$1.37M 0.22% 90
2021
Q2
$56.1M Sell
100,498
-971
-1% -$492K 0.2% 102
2021
Q1
$48M Buy
101,469
+59,448
+141% +$28.9M 0.18% 111
2020
Q4
$20.3M Sell
42,021
-115
-0.3% -$62.1K 0.08% 246
2020
Q3
$23.6M Sell
42,136
-991
-2% -$601K 0.11% 179
2020
Q2
$26.9M Buy
43,127
+8,012
+23% +$4.55M 0.13% 156
2020
Q1
$17.1M Buy
35,115
+9
+0% +$3.71K 0.1% 204
2019
Q4
$13.2M Buy
35,106
+112
+0.3% +$37.7K 0.06% 344
2019
Q3
$9.71M Sell
34,994
-1,680
-5% -$497K 0.05% 431
2019
Q2
$11.5M Buy
36,674
+179
+0.5% +$59.6K 0.05% 385
2019
Q1
$15M Buy
36,495
+760
+2% +$313K 0.07% 277
2018
Q4
$13.3M Hold
35,735
0.07% 273
2018
Q3
$14.4M Sell
35,735
-517
-1% -$197K 0.07% 308
2018
Q2
$12.5M Sell
36,252
-638
-2% -$200K 0.06% 352
2018
Q1
$12.7M Sell
36,890
-442
-1% -$154K 0.06% 350
2017
Q4
$14M Buy
37,332
+59
+0.2% +$23.9K 0.07% 325
2017
Q3
$16.7M Buy
37,273
+328
+0.9% +$156K 0.09% 247
2017
Q2
$18.1M Buy
36,945
+188
+0.5% +$82.3K 0.1% 213
2017
Q1
$14.2M Buy
36,757
+927
+3% +$344K 0.08% 286
2016
Q4
$13.2M Sell
35,830
-2,341
-6% -$890K 0.08% 294
2016
Q3
$15.3M Sell
38,171
-1,593
-4% -$639K 0.09% 244
2016
Q2
$13.9M Buy
39,764
+899
+2% +$346K 0.08% 286
2016
Q1
$14M Sell
38,865
-1,394
-3% -$574K 0.08% 272
2015
Q4
$21.9M Sell
40,259
-3,360
-8% -$1.82M 0.13% 167
2015
Q3
$20.3M Buy
43,619
+368
+0.9% +$198K 0.12% 181
2015
Q2
$22.1M Buy
43,251
+475
+1% +$232K 0.12% 187
2015
Q1
$19.3M Sell
42,776
-273
-0.6% -$116K 0.1% 218
2014
Q4
$17.7M Sell
43,049
-5
-0% -$1.97K 0.09% 243
2014
Q3
$15.5M Sell
43,054
-8,606
-17% -$2.88M 0.09% 261
2014
Q2
$14.6M Buy
51,660
+4,632
+10% +$1.37M 0.08% 281
2014
Q1
$14.1M Buy
47,028
+582
+1% +$179K 0.08% 277
2013
Q4
$12.8M Buy
46,446
+53
+0.1% +$15.2K 0.08% 293
2013
Q3
$14.5M Buy
46,393
+1,464
+3% +$385K 0.09% 222
2013
Q2
$10.1M Buy
+44,929
New +$10.5M 0.07% 326

Other funds holding REGN

Retirement Systems of Alabama's REGN Position: Q2 2026 in Review

Retirement Systems of Alabama reduced its Regeneron Pharmaceuticals (REGN) stake by 0.32% in Q2 2026, selling an estimated $283K and leaving 127,869 shares worth $79.7M. The position accounts for 0.24% of the portfolio, ranked #72.

Retirement Systems of Alabama first reported a position in REGN in Q2 2013 and has held it in 53 quarters since. The position peaked at $99.1M in Q1 2026. 478 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Retirement Systems of Alabama held 127,869 shares of Regeneron Pharmaceuticals worth $79.7M as of Q2 2026.
  • Retirement Systems of Alabama sold 416 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $283K.
  • Regeneron Pharmaceuticals made up 0.24% of Retirement Systems of Alabama's portfolio in Q2 2026, its #72 holding.
  • Retirement Systems of Alabama first reported a position in Regeneron Pharmaceuticals in Q2 2013 and has held it in 53 quarters since.
  • Retirement Systems of Alabama's Regeneron Pharmaceuticals position peaked at $99.1M in Q1 2026.
  • 478 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Retirement Systems of Alabama's 13F filing for Q2 2026, filed 28 Jul 2026.